184 related articles for article (PubMed ID: 37217808)
1. Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA.
Zhou C; Weng J; Liu S; Zhou Q; Hu Z; Yin Y; Lv P; Sun J; Li H; Yi Y; Shen Y; Ye Q; Shi Y; Dong Q; Liu C; Zhu X; Ren N
Hepatol Int; 2023 Dec; 17(6):1461-1476. PubMed ID: 37217808
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.
Wang D; Xu Y; Goldstein JB; Ye K; Hu X; Xiao L; Li L; Chang L; Guan Y; Long G; He Q; Yi X; Zhang J; Wang Z; Xia X; Zhou L
Liver Int; 2020 Aug; 40(8):1997-2007. PubMed ID: 32279416
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.
Chen G; Cai Z; Li Z; Dong X; Xu H; Lin J; Chen L; Zhang H; Liu X; Liu J
Int J Cancer; 2018 Dec; 143(11):2862-2870. PubMed ID: 30183077
[TBL] [Abstract][Full Text] [Related]
4. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
Qi LN; Ma L; Wu FX; Chen YY; Xing WT; Jiang ZJ; Zhong JH; Chen ZS; Gong WF; Ye JZ; Li HH; Shang JJ; Xiang BD; Li LQ
Hepatol Int; 2021 Feb; 15(1):114-126. PubMed ID: 33495903
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma.
Cai Z; Chen G; Zeng Y; Dong X; Li Z; Huang Y; Xin F; Qiu L; Xu H; Zhang W; Su X; Liu X; Liu J
Clin Cancer Res; 2019 Sep; 25(17):5284-5294. PubMed ID: 31217202
[TBL] [Abstract][Full Text] [Related]
6. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
8. Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study.
Pommergaard HC; Yde CW; Ahlborn LB; Andersen CL; Henriksen TV; Hasselby JP; Rostved AA; Sørensen CL; Rohrberg KS; Nielsen FC; Rasmussen A
Mol Biol Rep; 2022 Feb; 49(2):1609-1616. PubMed ID: 34811635
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.
Cai H; Zhang Y; Zhang H; Cui C; Li C; Lu S
J Surg Oncol; 2020 May; 121(6):1007-1014. PubMed ID: 31995247
[TBL] [Abstract][Full Text] [Related]
10. Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis.
Wang Y; Zhu GQ; Yang R; Wang C; Qu WF; Chu TH; Tang Z; Yang C; Yang L; Zhou CW; Miao GY; Liu WR; Shi YH; Zeng MS
J Transl Med; 2023 Oct; 21(1):734. PubMed ID: 37853415
[TBL] [Abstract][Full Text] [Related]
11. Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma.
Xin Z; Li J; Zhang H; Zhou Y; Song J; Chen P; Bai L; Chen H; Zhou J; Chen J; Ying B
Front Oncol; 2022; 12():783109. PubMed ID: 35155229
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Fu Y; Yang Z; Hu Z; Yang Z; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Hepatol Int; 2022 Aug; 16(4):868-878. PubMed ID: 35674872
[TBL] [Abstract][Full Text] [Related]
13. Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study.
Zhu GQ; Liu WR; Tang Z; Qu WF; Fang Y; Jiang XF; Song SS; Wang H; Tao CY; Zhou PY; Huang R; Gao J; Sun HX; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Shi YH
Mol Oncol; 2022 Jan; 16(2):549-561. PubMed ID: 34543520
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
Beaufrère A; Caruso S; Calderaro J; Poté N; Bijot JC; Couchy G; Cauchy F; Vilgrain V; Zucman-Rossi J; Paradis V
J Hepatol; 2022 Feb; 76(2):343-352. PubMed ID: 34624411
[TBL] [Abstract][Full Text] [Related]
15. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
Cai ZX; Chen G; Zeng YY; Dong XQ; Lin MJ; Huang XH; Zhang D; Liu XL; Liu JF
Int J Cancer; 2017 Sep; 141(5):977-985. PubMed ID: 28543104
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
18. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
20. Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction.
Hao Y; Yang Q; He Q; Hu H; Weng Z; Su Z; Chen S; Peng S; Kuang M; Chen Z; Xu L
Eur J Med Res; 2022 Dec; 27(1):276. PubMed ID: 36464701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]